Product image of Miochol (Acetylcholine Chloride) supplied by GNH India

Miochol

Active Ingredient:
Acetylcholine Chloride
Origin:
EU

Miochol (Acetylcholine Chloride)

Acetylcholine Chloride, the active ingredient in Miochol, is a direct‑acting cholinergic (muscarinic) agonist presented as a sterile ophthalmic solution for intraocular use. It induces miosis and facilitates aqueous humor outflow, primarily employed during ocular surgical procedures to improve intra‑operative conditions.

GNH India supplies Miochol as a licensed, GDP‑compliant international pharmaceutical product serving hospitals, transplant centres and ophthalmic clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Customers benefit from reliable supply chains and responsive technical support.

Manufacturer / TM Owner

Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Miochol, a direct‑acting muscarinic agonist, is used in ophthalmic procedures that require pupil constriction.

  • Intraoperative miosis: produces a small pupil to improve access and visualization during cataract extraction, trabeculectomy, and other intraocular surgeries.
  • Diagnostic pupillary testing: temporarily constricts the pupil to assess muscarinic receptor function in ophthalmic examinations.
  • Gonioscopic facilitation: creates a constricted pupil that enhances angle visualization during anterior chamber angle assessment.

How It Works

  • Acetylcholine chloride binds directly to muscarinic receptors on the iris sphincter muscle, activating G‑protein coupled pathways that increase intracellular calcium. This triggers contraction of the sphincter, resulting in pupil constriction (miosis) and promotes outflow of aqueous humor, thereby aiding intra‑ocular pressure regulation during surgical manipulation.

Side Effects

Miochol may cause ocular and systemic reactions after administration.

Common Side Effects

  • Blurred vision: transient loss of visual clarity due to pupil constriction.
  • Eye pain or discomfort: mild irritation at the site of instillation.
  • Increased lacrimation: excessive tearing following the drop.
  • Headache: mild headache associated with ocular muscle spasm.
  • Brow ache: discomfort around the eyebrow region.

Serious or Rare Side Effects

  • Severe ocular inflammation: uveitis or iritis requiring immediate medical attention.
  • Corneal ulceration: damage to the corneal epithelium that can lead to vision loss.
  • Systemic cholinergic effects: bradycardia, hypotension, bronchospasm, or excessive salivation.

Precautions & Warnings

Before using Miochol, consider the following safety measures.

  • Assess ocular health: confirm absence of active infection or severe inflammation.
  • Avoid in narrow‑angle glaucoma: pupil constriction may precipitate angle closure.
  • Monitor systemic cholinergic signs: watch for bradycardia, hypotension, or bronchospasm.
  • Use with caution alongside anticholinergic agents: may reduce efficacy.
  • Prevent contamination: use sterile technique and discard after the recommended period.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Miochol can interact with other medications that affect cholinergic pathways.

Major Interactions (Avoid)

  • Systemic anticholinergics (e.g., atropine): may antagonize Miochol's miotic effect.
  • Cholinesterase inhibitors (e.g., pyridostigmine): can potentiate ocular cholinergic activity, increasing risk of adverse effects.

Moderate Interactions (Monitor Closely)

  • Other ocular miotics (e.g., pilocarpine): additive miosis may lead to excessive constriction.
  • Topical anesthetics: may enhance corneal absorption of acetylcholine.
  • Systemic cholinergic agents: monitor for signs of systemic cholinergic excess.

Frequently Asked Questions

Miochol contains acetylcholine chloride and is employed to induce temporary pupil constriction (miosis) during ocular surgeries such as cataract extraction, trabeculectomy, and other intra‑ocular procedures, facilitating better surgical access and visualization.

Acetylcholine chloride directly stimulates muscarinic receptors on the iris sphincter muscle, causing contraction of the muscle. This leads to pupil constriction and promotes aqueous humor outflow, which is useful during eye surgery to improve operative conditions.

The specific dose and administration schedule of Miochol are determined by the treating ophthalmologist based on the surgical protocol and patient factors. Prescribers set the appropriate volume and frequency for each procedure.

The safety of Miochol in pregnancy or while breastfeeding has not been definitively established. Clinicians should weigh potential benefits against unknown risks and consider alternative options when treating pregnant or nursing patients.

To request Miochol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Miochol (acetylcholine chloride) is a direct‑acting muscarinic agonist, whereas alternatives like pilocarpine are indirect cholinergic agents. Miochol provides rapid, short‑duration miosis, which can be advantageous for intra‑operative use, while other miotics may have longer action and different side‑effect profiles.

Miochol should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from light and moisture, and discard any remaining product after the labeled in‑use period to maintain sterility.

Miochol is administered as an intra‑ocular drop. The prescribed number of drops is instilled directly onto the ocular surface using aseptic technique, typically shortly before the surgical procedure begins.

Serious risks include severe ocular inflammation such as uveitis, corneal ulceration, and systemic cholinergic effects like bradycardia, hypotension, or bronchospasm. Immediate medical attention is required if any of these symptoms develop.

Miochol should be avoided in patients with narrow‑angle or acute angle‑closure glaucoma, active ocular infection, severe ocular inflammation, or known hypersensitivity to acetylcholine chloride. Caution is also advised for individuals on systemic anticholinergic or cholinesterase‑inhibiting medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.